Improved propionic acid and 5,6-dimethylbenzimidazole control strategy for vitamin B12 fermentation by Propionibacterium freudenreichii

J Biotechnol. 2015 Jan 10:193:123-9. doi: 10.1016/j.jbiotec.2014.11.019. Epub 2014 Nov 29.

Abstract

An efficient fermentation-strengthening approach was developed to improve the anaerobic production of vitamin B12 by cultivation process optimization with Propionibacterium freudenreichii. The effects of the byproduct propionic acid and the precursor 5,6-dimethylbenzimidazole (DMB) on vitamin B12 biosynthesis were investigated. Byproduct inhibition experiments showed that maintaining propionic acid concentration in broth below 10-20 g/L in the early stage and 20-30 g/L in the late stage can efficiently improve vitamin B12 biosynthesis. Batch fermentation indicated the occurrence of feed-back inhibition in intracellular intermediate biosynthesis. In addition, the incorporation of the precursor DMB depended on the fermentation level of the vitamin B12 intermediate. High vitamin B12 concentration (58.8 mg/L) and production (0.37 mg/g) were obtained with an expanded bed adsorption bioreactor by using the propionic acid and DMB control method. The optimum concentration and production of 59.5 and 0.59 mg/L h for vitamin B12 production were respectively achieved after five continuous batches.

Keywords: 5,6-Dimethylbenzimidazole; Expanded bed adsorption bioreactor; Feed-back inhibition; Propionic acid; Vitamin B12.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Benzimidazoles / pharmacology*
  • Bioreactors / microbiology
  • Fermentation / drug effects*
  • Propionates / analysis
  • Propionates / metabolism*
  • Propionibacterium / drug effects*
  • Propionibacterium / metabolism*
  • Vitamin B 12 / analysis
  • Vitamin B 12 / metabolism*

Substances

  • Benzimidazoles
  • Propionates
  • 5,6-dimethylbenzimidazole
  • propionic acid
  • Vitamin B 12